These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29940625)

  • 21. Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.
    Lett TA; Walter H; Brandl EJ
    CNS Drugs; 2016 Dec; 30(12):1169-1189. PubMed ID: 27752945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The convergence of conventional therapeutic drug monitoring and pharmacogenetic testing in personalized medicine: focus on antidepressants.
    Sjöqvist F; Eliasson E
    Clin Pharmacol Ther; 2007 Jun; 81(6):899-902. PubMed ID: 17392719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic studies: a tool to improve antidepressant therapy.
    Ramos M; Berrogain C; Concha J; Lomba L; García CB; Ribate MP
    Drug Metab Pers Ther; 2016 Dec; 31(4):197-204. PubMed ID: 27889704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic and clinical significance of neuroimagistic and neurobiological vulnerability markers in correlation with the molecular pharmacogenetic testing in psychoses and ultra high-risk categories.
    Nussbaum LA; Hogea LM; Andreescu NI; Grădinaru RC; Puiu M; Todica A
    Rom J Morphol Embryol; 2016; 57(3):959-967. PubMed ID: 28002511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomic Characterization of Childbearing-Aged Individuals With Mood Disorders in a Tertiary Care Perinatal Mental Health Clinic.
    Mayer JLW; Betcher HK; Rasmussen-Torvik LJ; Yang A; George AL; Abramova T; Stika CS; Wisner KL; Clark CT; Gollan J
    J Clin Psychiatry; 2024 Jun; 85(2):. PubMed ID: 38874574
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogenetics of antipsychotic-induced weight gain.
    Correll CU; Malhotra AK
    Psychopharmacology (Berl); 2004 Aug; 174(4):477-89. PubMed ID: 15243737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.
    Risselada AJ; Mulder H; Heerdink ER; Egberts TC
    Pharmacogenomics; 2011 Aug; 12(8):1213-27. PubMed ID: 21843067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine.
    Nassan M; Nicholson WT; Elliott MA; Rohrer Vitek CR; Black JL; Frye MA
    Mayo Clin Proc; 2016 Jul; 91(7):897-907. PubMed ID: 27289413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of pharmacogenetic tests in antidepressive medication therapy].
    Kirchheiner J; Sasse J; Roots I; Brockmöller J; Bauer M
    Nervenarzt; 2005 Nov; 76(11):1340-54. PubMed ID: 15864514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does pharmacogenetic testing for CYP450 2D6 and 2C19 among patients with diagnoses within the schizophrenic spectrum reduce treatment costs?
    Herbild L; Andersen SE; Werge T; Rasmussen HB; Jürgens G
    Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):266-72. PubMed ID: 23731498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibility of a pharmacogenetic approach for prediction and personalized medication in major depressive disorder treatment].
    Kato M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):83-92. PubMed ID: 20491282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the Danish populations' preferences for pharmacogenetic testing using a discrete choice experiment. The case of treating depression.
    Herbild L; Bech M; Gyrd-Hansen D
    Value Health; 2009 Jun; 12(4):560-7. PubMed ID: 18980634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
    Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
    J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.
    Bousman CA; Forbes M; Jayaram M; Eyre H; Reynolds CF; Berk M; Hopwood M; Ng C
    BMC Psychiatry; 2017 Feb; 17(1):60. PubMed ID: 28178974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.
    Manworren RC; Jeffries L; Pantaleao A; Seip R; Zempsky WT; Ruaño G
    Clin J Pain; 2016 Feb; 32(2):109-15. PubMed ID: 25803758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attitudes about antidepressants: influence of information about weight-related side effects.
    Cash TF; Brown MA
    Percept Mot Skills; 2000 Apr; 90(2):453-6. PubMed ID: 10833739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetic testing in psychiatry: a review of features and clinical realities.
    de Leon J; Arranz MJ; Ruaño G
    Clin Lab Med; 2008 Dec; 28(4):599-617. PubMed ID: 19059065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.